Mesenchymal stem cells alleviate psoriasis-like dermatitis in mice by inhibiting TYK2 phosphorylation
Objective To investigate the effect of mesenchymal stem cells (MSCs) on TYK2 phosphorylation in psoriasis-like dermatitis induced by imiquimod cream in mice. Methods The mouse model of psoriasis-like dermatitis was induced by imiquimod cream (IMQ). The mice were randomly divided into blank group, IM...
Saved in:
Main Authors: | Lina LIANG (Author), Qingyan LUO (Author), Huan WANG (Author), Suyun JI (Author) |
---|---|
Format: | Book |
Published: |
editoiral office of Journal of Diagnosis and Therapy on Dermato-venereology,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TYK2 in Immune Responses and Treatment of Psoriasis
by: Shang L, et al.
Published: (2022) -
Curcumin Alleviates Epidermal Psoriasis-Like Dermatitis and IL-6/STAT3 Pathway of Mice
by: Cai Z, et al.
Published: (2023) -
Human urine-derived stem cells: potential therapy for psoriasis-like dermatitis in mice
by: Munhkjargal NasanOchir, et al.
Published: (2024) -
Use of TYK2 inhibitor to relieve reactive granulomatous dermatitis due to myelodysplastic syndrome
by: Christina Huang, BS, et al.
Published: (2023) -
Deucravacitinib is an allosteric TYK2 protein kinase inhibitor FDA-approved for the treatment of psoriasis
by: Robert Roskoski, Jr
Published: (2023)